Table 4.
Symptom distribution of gastrointestinal tumor and leiomyoma patients before and after endoscopic submucosal dissection
| Epigatric pain | Heartburn | Regurgitation | Discomfort | Nausea and vomiting | Bloating | Eructation | ||
| GIST | Pre- ESD | 50% (26/52) | 28.8% (15/52) | 34.6% (18/52) | 38.5% (20/52) | 19.2% (10/52) | 44.2% (23/52) | 28.8% (15/52) |
| n = 52 | Post- ESD | 9.6%a (5/52) | 11.5%a (6/52) | 17.3%a (9/52) | 26.9% (14/52) | 3.8%a (2/52) | 19.2%a (10/52) | 17.3% (9/52) |
| Leiomyoma | Pre- ESD | 38.7% (12/31) | 32.2% (10/31) | 32.2% (10/31) | 64.5%c (20/31) | 16.1% (5/31) | 45.1% (17/31) | 35.5% (11/31) |
| n = 31 | Post- ESD | 16.1% (5/31) | 25.8% (8/31) | 25.8% (8/31) | 41.9% (13/31) | 6.4% (2/31) | 19.4%a (6/31) | 16.1% (5/31) |
a
P < 0.05 vs the same group before treatment;
c
P < 0.05 vs GIST group. GIST: Gastrointestinal tumor; ESD: Endoscopic submucosal dissection.